1. Preliminary studies on SL75212, a new potent cardioselective β-adrenoceptor antagonist;Boudot;Br. J. Pharmacol.,1979
2. Betaxolol a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension;Beresford;Drugs,1986
3. Clinical evaluation of betaxolol (kerlone) as a once-daily treatment for hypertension in 4685 patients;Djian;Br. J. Clin. Practice,1985
4. Pharmacokinetics of the new β-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration;Bianchetti;Arzneimittelforschung,1980
5. Blood concentration and pharmacodynamic effects of betaxolol (SL 75212) a new beta adrenoceptor antagonist after oral and intravenous administration;Warrington;Br. J. Clin. Pharmacol.,1980